Ademi LLP Investigates Claims of Securities Fraud against PROCEPT BioRobotics Corporation [Accessibility Statement] Skip NavigationMILWAUKEE, Feb. 26, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against PROCEPT BioRobotics (NASDAQ: PRCT). The investigation results from inaccurate statements PROCEPT BioRobotics may have made regarding its financial statements, business operations and prospects.Click [here] to join our investigation or to obtain additional information, or ...